Inside Nigeria’s Growing Ulcer Treatment Gap
Tolulope Oke
In gastroenterology clinics across Lagos, Ibadan and Port Harcourt, a pattern is becoming difficult to ignore. Patients arrive having already completed a standard course of treatment, sometimes more than once. They have taken the antibiotics, endured the side effects, and waited for an improvement that did not last.
The treatment that is working less often
The standard prescription for Helicobacter pylori, the bacterium implicated in the majority of peptic ulcer cases is triple therapy: two antibiotics and a proton pump inhibitor, taken over seven to fourteen days. The problem is that it is working less reliably in Nigeria than it once did.
Antibiotic resistance is at the centre of this failure. A 2007 study published in African Health Sciences found metronidazole resistance rates in Nigerian H. pylori strains that rendered one of the core triple-therapy antibiotics largely ineffective. A 2019 review in the World Journal of Gastroenterology found resistance exceeding 70 percent for key antibiotics in Nigerian clinical isolates, with some studies approaching 100 percent for metronidazole.
The result is a cycle practitioners describe with familiar frustration: a patient is treated, achieves partial relief, relapses, and returns. The underlying infection is never fully resolved.
What pharmacists are seeing
At the community pharmacy level, the same shift appears in a different form. Several pharmacists interviewed for this report noted rising demand for non-prescription digestive aids from patients whose prescribed antibiotic courses had not been held.
Across online platforms and WhatsApp groups focused on chronic illness, patients who have cycled through standard pharmaceutical options are increasingly arriving at herbal formulations among them are products like Herbit Herbal Mixture, a NAFDAC-registered herbal suspension carrying registration number A7-4324L.
Why the science is being taken seriously
The case for plant-based compounds in ulcer management is no longer peripheral. A 2022 systematic review in the Journal of Ethnopharmacology examined 107 peer-reviewed studies and identified 360 African plant species with documented anti-ulcer or anti-H. pylori activity. A 2003 study in Helicobacter found lemongrass oil demonstrated zero resistance across ten serial exposures to H. pylori in laboratory conditions, a result that contrasts sharply with resistance patterns documented for standard antibiotics in Nigerian clinical settings.
The treatment gap is real and measurable. Patients are navigating it. What is changing is that more of those decisions are arriving at the same place and the pattern is now consistent enough to warrant examination.
This article is for informational purposes only and does not constitute medical advice.
